Literature DB >> 32118677

Home blood pressure monitoring and e-Health: investigation of patients' experience with the Hy-Result system.

Nicolas Postel-Vinay1, Olivier Steichen2,3, Emmanuelle Pébelier4, Alexandre Persu5, Elena Berra5,6, Guillaume Bobrie1, Sébastien Savard7, José Nogueria8, Michel Azizi1,9.   

Abstract

BACKGROUND: Hy-Result is a validated system designed to help patients complying with the home blood pressure monitoring (HBPM) protocol and understanding their blood pressure (BP) readings. It is available as a standalone web application or within a wireless BP monitor app.
OBJECTIVE: The aim of the study was to explore patients' experience with Hy-Result.
METHODS: Online survey completed by 512 users of the Hy-Result web application or monitor app, and three focus groups with 24 hypertensive patients who monitor their BP at home and use the Hy-Result web application to record their data. We assessed the experience of patients with the functionalities and medical content of Hy-Result, their feelings and expectations, and the impact of Hy-Result on the physician-patient relationship.
RESULTS: (1) Functionalities: Over 90% of survey respondents and all focus group participants found Hy-Result easy to use. The main drawback of the web application is the need to manually enter all BP values at once. (2) Medical content: Hy-Result offers information on arterial hypertension and HBPM that most patients found useful. Users found that Hy-Result triggers appropriate reactions to BP readings, including adequately timed general practitioner visits. (3) Feelings and expectations: Over 90% of survey respondents trust Hy-Result and focus group participants understood that text messages are suggestions, not diagnoses. Hy-Result did not cause anxiety or excessive BP measurements. (4) Physician-patient relationship: Three-quarter of survey respondents agreed that Hy-Result may help when talking with their doctor about their BP values but only one-third of those have shown the report to their physician. For focus group participants, using Hy-Result should ideally be a physician prescription. They were aware that Hy-Result does not replace clinical judgment and that physicians still have a decisive role in BP management.
CONCLUSION: Most of the users described Hy-Result as an easy-to-use and useful tool. Patients are willing to use it on physician request.

Entities:  

Mesh:

Year:  2020        PMID: 32118677     DOI: 10.1097/MBP.0000000000000436

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  5 in total

1.  Comparing the Acceptance of Mobile Hypertension Apps for Disease Management Among Patients Versus Clinical Use Among Physicians: Cross-sectional Survey.

Authors:  Bernhard Breil; Christel Salewski; Jennifer Apolinário-Hagen
Journal:  JMIR Cardio       Date:  2022-01-06

Review 2.  Home Blood Pressure and Telemedicine: A Modern Approach for Managing Hypertension During and After COVID-19 Pandemic.

Authors:  Barbara Citoni; Ilaria Figliuzzi; Vivianne Presta; Massimo Volpe; Giuliano Tocci
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-12-02

3.  Home Blood Pressure Measurement and Self-Interpretation of Blood Pressure Readings During Pregnancy: Hy-Result e-Health Prospective Study.

Authors:  Nicolas Postel-Vinay; Jiali-Delphine Shao; Anne Pinton; Aude Servais; Nicole Gebara; Laurence Amar
Journal:  Vasc Health Risk Manag       Date:  2022-04-15

4.  Towards a Reliable and Rapid Automated Grading System in Facial Palsy Patients: Facial Palsy Surgery Meets Computer Science.

Authors:  Leonard Knoedler; Helena Baecher; Martin Kauke-Navarro; Lukas Prantl; Hans-Günther Machens; Philipp Scheuermann; Christoph Palm; Raphael Baumann; Andreas Kehrer; Adriana C Panayi; Samuel Knoedler
Journal:  J Clin Med       Date:  2022-08-25       Impact factor: 4.964

5.  Patient-initiated cardiovascular monitoring with commercially available devices: How useful is it in a cardiology outpatient setting? Mixed methods, observational study.

Authors:  Christine A'Court; Wilfred Jenkins; Claire Reidy; Chrysanthi Papoutsi
Journal:  BMC Cardiovasc Disord       Date:  2022-09-29       Impact factor: 2.174

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.